Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Tango Therapeutics (TNGX) Profit After Tax: 2020-2024

Historic Profit After Tax for Tango Therapeutics (TNGX) over the last 5 years, with Dec 2024 value amounting to -$130.3 million.

  • Tango Therapeutics' Profit After Tax rose 154.46% to $15.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$100.5 million, marking a year-over-year increase of 18.54%. This contributed to the annual value of -$130.3 million for FY2024, which is 28.07% down from last year.
  • According to the latest figures from FY2024, Tango Therapeutics' Profit After Tax is -$130.3 million, which was down 28.07% from -$101.7 million recorded in FY2023.
  • Tango Therapeutics' 5-year Profit After Tax high stood at -$52.0 million for FY2020, and its period low was -$130.3 million during FY2024.
  • Its 3-year average for Profit After Tax is -$113.4 million, with a median of -$108.2 million in 2022.
  • In the last 5 years, Tango Therapeutics' Profit After Tax slumped by 85.76% in 2022 and then grew by 5.95% in 2023.
  • Over the past 5 years, Tango Therapeutics' Profit After Tax (Yearly) stood at -$52.0 million in 2020, then decreased by 12.05% to -$58.2 million in 2021, then plummeted by 85.76% to -$108.2 million in 2022, then increased by 5.95% to -$101.7 million in 2023, then dropped by 28.07% to -$130.3 million in 2024.